8 December 2025NewsEuropeMarisa Woutersen

Marks & Clerk adds multi-jurisdictional disputes expert

The firm has added a disputes specialist with experience in pharma, biotech and manufacturing sectors across multiple jurisdictions.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

UPC confirms validity of Edwards Lifesciences heart valve tech patent

23 July 2024 Paris Central Division issues its first revocation judgment in dispute brought by Meril subsidiaries in Italy, Germany and India | Decision means infringement action by Edwards can resume at Munich Local Division | Damages worth €8m ($8.7m) | Gide, Marks & Clerk, Potter Clarkson among representatives.

Biotechnology

The fall of COVID-19 and the rise of antimicrobial resistance

17 March 2022 With evidence of antimicrobial resistance increasing, can innovation incentives drive pharma to fight back? Donald McNab and Mark Schuster of Marks & Clerk explore.

Europe

UK experimental use exemptions: Part 4—the SPC manufacturing and stockpiling waiver

10 August 2021 In the final article of a four-part series, Sophie Topham of Marks & Clerk discusses the supplementary protection certificate manufacturing waiver.

More features

USPTO issues guidance to support patent eligibility declarations

Chest-worn heart monitor tech flatlines in US patent appeal

Novo Nordisk India strategy suffers semaglutide patent setback

FedCirc voids Seagen patent in $41m cancer treatment dispute

Blank Rome expands team with Chicago partner

FisherBroyles grows IP practice with experienced patent attorney

New IP guidance promises to transform the NHS. Will it deliver?

UPC draws hard line on urgency in first SPC dispute

Marks & Clerk adds multi-jurisdictional disputes expert

More on this story

Editor's picks

Editor's picks

More features